30 likes | 38 Views
Noteworthy growth in the incidences of neurological disorders and autoimmune diseases across the globe is projected to help in the expansion of the global intravenous immunoglobulin (IVIG) market, according to a new study published by TMR. The study notes that the market will develop at 8.1% CAGR during forecast period 2018 to 2026.<br><br>
E N D